Bridge Pharmaceuticals Pvt. Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Bridge Pharmaceuticals Pvt. Ltd.
Going Deeper Into China: AstraZeneca Strikes Drug Discovery Partnership With CRO Pharmaron
AstraZeneca continues its investments in China, setting up a comprehensive discovery partnership with Chinese CRO Pharmaron, which acquired preclinical CRO Bridge in 2010.
Going Deeper Into China: AstraZeneca Strikes Drug Discovery Partnership With CRO Pharmaron
AstraZeneca continues its investments in China, setting up a comprehensive discovery partnership with Chinese CRO Pharmaron, which acquired preclinical CRO Bridge in 2010.
Ascletis Raises Mammoth $100 Million To Deploy Its US-China Hybrid Model
In the latest and most ambitious attempt to create a new global pharma with one foot in China and one in the West, Ascletis Inc. has launched with a hybrid drug development model that has attracted $100 million in committed funding.
China: The Asian Dragon Lures Foreign Investors
WuXi PharmaTech's spectacular public offering last summer piqued foreign investors' interest. Top tier VC firms are now investing in contract research organizations, manufacturing plays, and start-ups shifting business operations to China.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice